These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 6436732)
21. Effect of valproate, sodium 2-propyl-4-pentenoate and sodium 2-propyl-2-pentenoate on renal substrate uptake and ammoniagenesis in the rat. Elhamri M; Ferrier B; Martin M; Baverel G J Pharmacol Exp Ther; 1993 Jul; 266(1):89-96. PubMed ID: 8331578 [TBL] [Abstract][Full Text] [Related]
23. Valproate-induced hyperammonemia: role of diet. Marescaux C; Warter JM; Rumbach L; Micheletti G; Chabrier G; Imler M World Rev Nutr Diet; 1984; 43():174-8. PubMed ID: 6433563 [No Abstract] [Full Text] [Related]
24. [Hyperammonemia during sodium valproate therapy: clinically relevant or accidental finding?]. Ettlin T; Scollo-Lavizzari G Schweiz Rundsch Med Prax; 1986 Jul; 75(29):881-5. PubMed ID: 3090672 [No Abstract] [Full Text] [Related]
25. [Encephalopathy associated with hyperammonemia in an alcoholic patient treated with sodium valproate]. Mattei A; Bernard G; Plauchu G; Paliard P Gastroenterol Clin Biol; 1993; 17(6-7):516-7. PubMed ID: 8243949 [No Abstract] [Full Text] [Related]
26. [Renal glutamine metabolism in man during treatment with sodium valproate]. Warter JM; Marescaux C; Chabrier G; Rumbach L; Micheletti B; Imler M Rev Neurol (Paris); 1984; 140(5):370-1. PubMed ID: 6431585 [TBL] [Abstract][Full Text] [Related]
27. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status. Hamed SA; Abdella MM Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440 [TBL] [Abstract][Full Text] [Related]
32. Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures. Petroff OA; Rothman DL; Behar KL; Hyder F; Mattson RH Seizure; 1999 Apr; 8(2):120-7. PubMed ID: 10222306 [TBL] [Abstract][Full Text] [Related]
33. Severe acute hyperammonemia after brief exposure to valproate. Eubanks AL; Aguirre B; Bourgeois JA Psychosomatics; 2008; 49(1):82-3. PubMed ID: 18212182 [TBL] [Abstract][Full Text] [Related]
34. Valproate as a cause of hyperammonemia in heterozygotes with ornithine-transcarbamylase deficiency. Leão M Neurology; 1995 Mar; 45(3 Pt 1):593-4. PubMed ID: 7898728 [No Abstract] [Full Text] [Related]
38. Enhancement of circulatory antioxidants by alpha-ketoglutarate during sodium valproate treatment in Wistar rats. Murugesan V; Subramanian P Pol J Pharmacol; 2003; 55(1):31-6. PubMed ID: 12856823 [TBL] [Abstract][Full Text] [Related]
39. New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA. Aires CC; van Cruchten A; Ijlst L; de Almeida IT; Duran M; Wanders RJ; Silva MF J Hepatol; 2011 Aug; 55(2):426-34. PubMed ID: 21147182 [TBL] [Abstract][Full Text] [Related]